EmERGE reaches first key milestone with very positive opinion from the EU Commission

Updated: Jan 2, 2019

The EU Commission’s report highlighted that impressive work has been done so far and that the project was a very good example of multisectorial collaboration with potential to transfer results to other countries and/or other diseases. The project was praised for contributing to the state-of-the-art within the first year through the comprehensive situation analysis, which has been carried out in five countries, and for the preparation of an mHealth platform with meaningful integration of research, clinical work and patients needs. The report also noted that regular and detailed monitoring was essential to keep the project on track and recommended targeting additional stakeholders to inform them about the project results and its potential impact. The report proposed broader dissemination activities to translate the knowledge/information to other communities, clinicians and patients groups.


#PressRelease #EUCommission

31 views0 comments

Recent Posts

See All
Project Members
European AIDS Treatment Group
University of Sussex
University of Brighton
Klinika Za İnfektivne Bolesti "Dr. Fran Mihaljević" - Croatia
Centro Hospitalar De Lisboa Central, Epe - Portugal
Brighton And Sussex University Hospitals NHS Trust - United Kingdom
EmERGE mHEALTH LTD. - Horizontal Transpa
Institute of Tropical Medicine Antwerp
Modus Ltd
Universidad Politecnica De Madrid - Spain
Contact Us

EmERGE Project/European AIDS Treatment Group

Tel: +32 2 626 96 40

Address: Interoffices | Avenue des Arts 56-4c
1000 Brussels, Belgium

Email: projects@eatg.org

Website: www.emergeproject.eu

The EmERGE Project has received funding from the European Union's Horizon 2020. Research and Innovation Programme under Grant Agreement No:643736